1997361-87-1

Lixisenatide acetate salt is a useful research chemical used to increase proliferation of pancreatic beta cells in transplate patients with a DYRK1 A inhibitor and a GLP1R agonist.

[1] CHRISTIAN THORKILDSEN. Glucagon-like peptide 1 receptor agonist ZP10A increases insulin mRNA expression and prevents diabetic progression in db/db mice.[J]. Journal of Pharmacology and Experimental Therapeutics, 2003, 307 2: 490-496. DOI: 10.1124/jpet.103.051987
[2] D TEWS  J E  U Werner. Enhanced protection against cytokine- and fatty acid-induced apoptosis in pancreatic beta cells by combined treatment with glucagon-like peptide-1 receptor agonists and insulin analogues.[J]. Hormone and Metabolic Research, 2008, 40 3: 172-180. DOI: 10.1055/s-2008-1042426